跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,518 条关于
“Woodline Partners LP”
全部
5,518
临床试验
868
药物
178
机构
76
资讯
4,396
去年
Tango Therapeutics Secures $225 Million in Financing to Advance Precision Cancer Medicine Pipeline
9个月前
Kalaris Therapeutics Secures $50 Million Funding to Advance TH103 for Neovascular AMD Treatment
去年
Rezolute Secures $90 Million in Public Offering to Advance Rare Disease Therapies
去年
SAB BIO Secures $175 Million Funding to Advance Type 1 Diabetes Immunotherapy Through Phase 2b Trial
去年
Lexeo Therapeutics Secures $80M Financing to Advance Genetic Heart Disease Therapies
8个月前
Diagonal Therapeutics Secures $125M Series B to Advance First-in-Class Clustering Antibody DIAG723 for Rare Genetic Diseases
去年
Everest Medicines Invests $30.9M in I-Mab Following Promising 83% Response Rate for Gastric Cancer Bispecific Antibody
28天前
Werewolf and Ambros Therapeutics Announce Merger to Advance Neridronate as Potential First FDA-Approved Treatment for CRPS-1
去年
Lantern Pharma Secures European Patent for AI-Developed Cancer Therapy LP-284
去年
LP-184 Receives FDA Fast Track Designation for Triple Negative Breast Cancer
第 1 页,共 440 页
上一页
下一页